Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
02/2005
02/16/2005EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers
02/16/2005CN1189446C New derivatives of 6-(4-phenylbutoxy) hexylamine and process for producing salmeterol
02/15/2005US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders
02/15/2005US6855830 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
02/10/2005WO2005012284A1 4,5-DIHYDRONAPHTHO[1,2-b]THIOPHENE DERIVATIVE
02/10/2005WO2005012280A1 Alkynyl aryl carboxamides
02/10/2005WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity
02/10/2005WO2005012179A2 Supercritical water or subcritical water and method of oxidizing organic substance with the same
02/10/2005WO2004077511A3 (meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained
02/10/2005US20050032875 Process for the preparation of indole derivatives
02/10/2005DE10333379A1 Acetale, ihre Verwendung als Reichstoffe und Verfahren zu ihrer Herstellung Acetals, their use as Reich materials and processes for their preparation
02/10/2005CA2527861A1 Alkynyl aryl carboxamides
02/09/2005CN1578663A Inhibitors of histone deacetylase
02/03/2005WO2005009985A1 Production of trimethylene carbonate from poly(trimethylene carbonate) by wiped film reactive evaporation
02/03/2005WO2005009984A1 Acetals, use thereof as fragrances and methods for production thereof
02/03/2005WO2005009104A2 Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
02/03/2005US20050026998 Aldoxanes such as 2,6-dipropyl-5-ethyl-1,3-dioxan-4-ol made by the self-reaction of aldehydes; they protect an active aldehyde such as a perfumery or flavor aldehyde, from a chemically aggressive medium
02/03/2005US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
02/03/2005US20050026907 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions
02/03/2005US20050026785 Novel phenyl-propargylether derivatives
02/03/2005CA2533408A1 Production of trimethylene carbonate from poly(trimethylene carbonate) by wiped film reactive evaporation
02/02/2005EP1501786A1 Biphenyl carboxamides
02/02/2005EP1025079B1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
02/02/2005EP0722445B1 Degradable polydioxaneone-based materials
02/02/2005CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
02/01/2005US6849747 Fluorinated and alkylated dibenzylidene alditol derivatives
02/01/2005US6849739 N-heterocyclic derivatives as NOS inhibitors
02/01/2005US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N
02/01/2005US6849649 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
01/2005
01/27/2005WO2005007621A2 Ubiquitin ligase inhibitors
01/27/2005US20050020807 Production of trimethylene carbonate from poly (trimethylene carbonate) by wiped film reactive evaporation
01/27/2005US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
01/26/2005EP1499306A2 Bicyclic amides
01/26/2005CN1186338C Method for catalytically synthesizing 1, 4-dioxane using granular solid super strong acid
01/25/2005US6846829 N-heterocyclic derivatives as NOS inhibitors
01/20/2005US20050014936 made by tetrazotizing a benzidine derivative and coupling with a diketone such as 1,3-cyclohexanedione heating and separating; special effect printing, security printing or in the optoelectronic field
01/20/2005US20050014727 Antiinflammatoy agents; antiallergens; antiproliferative agents; skin disorders; viral disorders; Alzheimer's disease; muscular disorders; antiarthritic agents
01/19/2005CN1566351A Process for producing optically active 2-[6-(hydroxymethyl)-1, 3-dioxan-4-yl]acetic acid derivatives
01/19/2005CN1566096A Prostaglandin agonists and their use to treat bonedisorders
01/18/2005US6844446 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
01/18/2005US6844437 Chemical intermediates; anticholesterol agents, antilipemic agents
01/18/2005US6844404 Catalyst compositions for the polymerization of olefins
01/18/2005US6844032 Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices
01/13/2005US20050009872 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
01/13/2005US20050009871 Ubiquitin ligase inhibitors
01/13/2005US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
01/13/2005US20050009706 Herbicides; plant safening agents
01/12/2005EP1494995A1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
01/12/2005CN1562998A Method for synthesizing compound in condensed carbonyl group
01/11/2005US6841674 N-heterocyclic derivatives as NOS inhibitors
01/11/2005US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
01/11/2005US6841550 Benzoxazine and benzothiazine derivatives and their use in medicines
01/06/2005WO2005000832A1 1,4-benzodioxane sulfonic acid compound and use thereof as electron-acceptor material
01/06/2005WO2005000233A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
01/06/2005US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase
01/06/2005US20050004093 Using 6-betahydroxymethylpenicillanic acid sulfone; bactericides; therapy for bacteria infections in mammals
01/06/2005US20050001200 Mixture; electrooptics
01/06/2005CA2530581A1 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
01/05/2005EP1492822A1 Cross-linked polymers based on cyclodextrins for removing polluting agents
01/05/2005CN1183075C Benzene derivative and its prepn. method
01/04/2005US6838568 A nucleating agents for plastic, especially improving the optical properties; food or cosmetic containers and packagings, gelling agents for preparation of antiperspirant gel sticks
01/04/2005CA2147155C Amide derivatives
12/2004
12/29/2004WO2004113314A1 Novel boronate esters
12/29/2004CN1182103C Novel ethylamine derivatives
12/29/2004CN1181817C NF-KB inhibitors containing phenylmethyl benzoquinone as active ingredient
12/28/2004US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
12/28/2004US6835427 Optically active compound and liquid crystal composition containing the compound
12/23/2004WO2004110418A2 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
12/23/2004US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis
12/23/2004US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents
12/23/2004DE10326195A1 Geschützte 5,7-Dihydroxy-4,4-dimethyl-3-oxoheptansäureester und 5,7-Dihydroxy-2-alkyl-4,4-dimethyl-3-oxoheptansäureester für die Synthese von Epothilonen- und Derivaten und Verfahren zur Herstellung dieser Ester Protected 5,7-dihydroxy-4,4-dimethyl-3-oxoheptansäureester and 5,7-dihydroxy-2-alkyl-4,4-dimethyl-3-oxoheptansäureester for the synthesis of Epothilonen- and derivatives and methods for preparing these esters
12/23/2004CA2528003A1 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
12/22/2004EP1487815A1 Compounds for the controlled release of active aldehydes
12/22/2004EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents
12/22/2004EP1086076B1 Sulfonamide inhibitors of aspartyl protease
12/22/2004CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/21/2004CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
12/16/2004WO2004108733A1 Beta-lactamase inhibitor prodrug
12/16/2004WO2004108697A1 Protected 5,7-dihydroxy-4,4-dimethyl-3-oxoheptanoic acid esters and 5,7-dihydroxy-2-alkyl-4,4-dimethyl-3-oxoheptanoic acid esters for synthesizing epothilones and derivatives derivatives, and methods for producing these esters
12/16/2004US20040254391 Preparation of aliphatic nitriles substituted in the 3 and 5 positions with hydroxyls or protected hydroxyls in the presence of an organic solvent and a phase transfer catalyst
12/16/2004US20040254237 Acid amide derivatives, process for producing these, and pest agent containing these
12/16/2004DE102004021334A1 New aldehyde compounds with difluorooxymethylene bridges are useful for the production of liquid crystal displays
12/16/2004DE102004020461A1 Liquid crystalline medium for use in electro-optical displays, contains at least one compound with a 4-substituted benzene ring linked to a 1,3-dioxan-2-yl-cyclohexane system by an oxydifluoromethylene group
12/16/2004CA2528065A1 Beta-lactamase inhibitor prodrug
12/15/2004EP1486491A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
12/14/2004US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/09/2004WO2004092106A3 Process for preparing alkoxy- and aryloxy-phenols
12/09/2004WO2004078144A3 Diphenylethylene compounds and uses thereof
12/09/2004US20040249098 (Meth)acrylic and (meth)acrylamide monomers comprising cyclic acetal/thioacetal groups, polymerizable compositions, and polymers obtained
12/09/2004CA2525282A1 Indole derivatives with an improved antipsychotic activity
12/08/2004EP1484301A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
12/08/2004EP1483256A2 Process for making chiral 1,4-disubstituted piperazines
12/08/2004EP1483255A1 Process for synthesizing chiral n-aryl piperazines
12/07/2004US6828446 Aromatic thioether liver X-receptor modulators
12/07/2004US6827876 Using alpha, alpha -difluorocyclohexylidene derivative as starting material to obtain difluoromethyl ether derivative
12/02/2004WO2004103560A1 Catalytic composition and process for asymmetric hydrogenation
12/02/2004US20040242928 Reverse hydroxamic acid derivatives
12/02/2004US20040242905 Forming a 1,3-dioxane compound
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 103